A carregar...

Adjuvant Chemotherapy in Uterine Leiomyosarcoma: Trends and Factors Impacting Usage

OBJECTIVES: The benefit of adjuvant chemotherapy in patients with localized uterine leiomyosarcoma (LMS) remains unclear due to a lack of randomized studies and data only from small retrospective series to rely on. We sought to identify factors associated with the administration of chemotherapy and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sarcoma
Main Authors: Patel, Dhara, Handorf, Elizabeth, von Mehren, Margaret, Martin, Lainie, Movva, Sujana
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6387708/
https://ncbi.nlm.nih.gov/pubmed/30881199
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/3561501
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!